Investment Rating - The investment rating for the construction materials industry is "Positive" (maintained) [1] Core Insights - The construction materials industry has made significant progress in energy conservation and carbon reduction, with six major sub-industries releasing carbon reduction technology guidelines and a notable increase in the share of clean energy [3][4] - The cement industry is expected to benefit from national policies aimed at controlling cement clinker production capacity and improving energy efficiency standards [3] - The report recommends several companies within the construction materials sector, including SanKeTree, Dongfang Yuhong, Weixing New Materials, and Jianlang Hardware, as well as beneficiaries like Beixin Building Materials and Haizhu Cement [3] Summary by Sections Market Performance - The construction materials index rose by 2.91% from August 18 to August 22, 2025, underperforming the CSI 300 index by 1.27 percentage points [4][13] - Over the past three months, the CSI 300 index increased by 13.42%, while the construction materials index rose by 16.67%, outperforming the CSI 300 by 3.25 percentage points [4][13] - In the past year, the CSI 300 index increased by 30.86%, and the construction materials index rose by 35.30%, outperforming the CSI 300 by 4.44 percentage points [4][13] Cement Sector - As of August 22, 2025, the average price of P.O42.5 bulk cement was 280.47 CNY/ton, reflecting a 1.94% increase from the previous period [6][24] - The clinker inventory ratio was 64.62%, showing a decrease of 1.56 percentage points [6][24] - Regional price trends varied, with notable increases in East China (+5.05%) and Central China (+6.53%), while South China saw a decrease of 2.82% [24][26] Glass Sector - The average spot price for float glass was 1187.88 CNY/ton, down by 1.78% from the previous period [6][81] - The inventory of float glass increased by 28 million weight boxes, a rise of 0.50% [6][83] - The price of photovoltaic glass remained stable at 116.41 CNY/weight box [6][87] Fiberglass Sector - The market prices for fiberglass remained stable, with some flexibility in transactions noted [6][19] - The report highlights the performance of various companies within the fiberglass sector, indicating a generally positive trend [6][19] Consumer Building Materials - The prices of raw materials for consumer building materials showed slight fluctuations, with specific price data provided for various materials [6][20]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company has experienced a decline in revenue and net profit in H1 2025, with revenue down 7.1% year-on-year to 1.79 billion yuan and net profit down 15.2% to 108 million yuan. The second quarter saw a more significant decline, with revenue down 11.7% and net profit down 16.1% [4] - The report anticipates a recovery in the company's profitability, focusing on the health sector, and maintains a reasonable valuation with the current price-to-earnings ratio (PE) at 35.2 for 2025 [4][5] Financial Performance Summary - H1 2025 revenue by segment: - Cosmetics: 1.094 billion yuan (down 7.7%), with a gross margin of 62.0% (up 0.6 percentage points) - Pharmaceuticals: 207 million yuan (down 13.9%), with a gross margin of 51.8% (down 0.3 percentage points) - Raw materials: 179 million yuan (up 4.2%), with a gross margin of 40.9% (up 1.7 percentage points) - Overall gross margin for H1 2025 was 52.4% (up 0.5 percentage points), indicating improved profitability [5][6] Earnings Forecast - The company has revised its profit forecasts for 2025-2027, now expecting net profits of 246 million yuan, 287 million yuan, and 329 million yuan respectively, with corresponding earnings per share (EPS) of 0.24, 0.28, and 0.32 yuan [4][7] Valuation Metrics - The current PE ratios for 2025, 2026, and 2027 are projected at 35.2, 30.2, and 26.4 respectively, indicating a declining trend in valuation multiples [7][10]

Investment Rating - The investment rating for the food and beverage industry is "Positive" (maintained) [1] Core Viewpoints - The food and beverage index increased by 3.3% from August 18 to August 22, ranking 10th among primary sub-industries, underperforming the CSI 300 by approximately 0.9 percentage points. Other liquor categories (+8.2%), soft drinks (+5.1%), and liquor (+3.6%) performed relatively better [11][12] - The current market liquidity is ample, pushing the valuation center of equity assets upward. The liquor sector, being a previously oversold category, has seen valuation improvements ahead of a recovery in fundamentals. Despite being under demand pressure, the liquor sector shows signs of improvement, with some brands performing better in August compared to June and July [11][12] - The report suggests focusing on three lines of investment: national mid-to-high-end recovery (e.g., Shede Liquor, Shanxi Fenjiu), regional leaders (e.g., Gujing Gongjiu, Jiansi Yuan), and high-end liquor valuation recovery (e.g., Luzhou Laojiao, Kweichow Moutai). Additionally, attention should be given to new consumption targets with strong growth potential [11][12] Market Performance - The food and beverage index's performance from August 18 to August 22 was 3.3%, ranking 10th out of 28 industries, and underperformed the CSI 300 by about 0.9 percentage points. Within the sub-industries, other liquor categories (+8.2%), soft drinks (+5.1%), and liquor (+3.6%) led the performance [12][13] Upstream Data - As of August 19, the GDT auction price for whole milk powder was $4036 per ton, up 0.6% month-on-month and up 15.9% year-on-year. Conversely, the domestic fresh milk price was 3.0 yuan per kilogram, down 0.3% month-on-month and down 5.9% year-on-year, indicating a downward trend in domestic milk prices [17][18] - On August 23, the price of pork was 20.1 yuan per kilogram, down 27.3% year-on-year, while the price of live pigs was 13.7 yuan per kilogram, down 32.6% year-on-year [19][20] Recommended Portfolio - Recommended stocks include Kweichow Moutai, Shanxi Fenjiu, Ximai Food, Wancheng Group, and Baijiu Co. Kweichow Moutai is expected to deepen its reform process and emphasize sustainable development despite short-term demand pressure. Shanxi Fenjiu has high mid-term growth certainty, while Ximai Food is expanding new channels and improving profitability [4]

Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Viewpoints - The new housing transaction area has increased month-on-month, consolidating the real estate market's stabilization trend [3][62] - Various policies are being implemented to support the real estate market, including flexible housing fund policies in multiple regions [4][14][15] Summary by Sections 1. Market Stabilization - The central government emphasizes strong measures to stabilize the real estate market, including urban renewal and improving housing supply [4][13] - Local governments are introducing supportive policies for housing funds to assist affected workers and promote housing consumption [14][15] 2. Sales Performance - In the 34th week of 2025, the transaction area of new homes in 68 major cities was 1.96 million square meters, a year-on-year decrease of 17% but a month-on-month increase of 12% [5][16] - The cumulative transaction area for new homes from the beginning of the year to date is 78.3 million square meters, with a year-on-year decrease of 10% [16] - The transaction area for second-hand homes in 20 cities was 1.85 million square meters, with a year-on-year growth of 6% [32] 3. Investment Trends - In the 34th week of 2025, 100 major cities launched land planning with a total area of 24.68 million square meters, with a transaction area of 14.55 million square meters, a year-on-year decrease of 34% [38] - The average transaction premium rate for land was 10.3% [38] 4. Financing Conditions - The issuance of domestic credit bonds decreased to 7.03 billion yuan, a year-on-year decrease of 2% and a month-on-month decrease of 13% [50][52] - The cumulative issuance of credit bonds is 267.58 billion yuan, a year-on-year decrease of 5% [50][54] 5. Weekly Market Review - The real estate index increased by 0.5%, underperforming compared to the Shanghai and Shenzhen 300 index, which rose by 4.18% [56][57] - The performance of individual stocks within the real estate sector varied, with notable increases in some stocks while others saw declines [59][61] 6. Investment Recommendations - The report maintains a "Positive" rating for the industry, anticipating further stabilization in the real estate market due to supportive policies [62]

Investment Rating - The industry investment rating is "Positive" (maintained) [2] Core Viewpoints - The report indicates that thermal coal prices are rebounding, aiming for a target of 750 CNY per ton, with a current price of 704 CNY per ton as of August 22, 2025, reflecting a 15.6% increase from the lowest price of 609 CNY per ton earlier this year [4][5] - The report emphasizes that both thermal coal and coking coal prices have reached a turning point, with expectations for further price recovery [5][13] Summary by Sections Thermal Coal Market - As of August 22, 2025, the Qinhuangdao Q5500 thermal coal price is 704 CNY/ton, with a 15.6% increase from the year's lowest price of 609 CNY/ton [4] - The operating rate of 442 coal mines in Shanxi, Shaanxi, and Inner Mongolia is 81.7%, indicating a relatively low supply level [4] - Port inventories have decreased by 29.82% from the highest level of 3,316.3 million tons earlier this year to 2,327.4 million tons [4] - The daily consumption of coal remains high during the summer, with the methanol operating rate at 80.65%, reflecting strong demand [4] Coking Coal Market - The price of coking coal at the Jing Tang Port is 1,610 CNY/ton, rebounding from a low of 1,230 CNY/ton in early July, with a significant increase of 61.61% in futures prices [4][5] - The report notes a tightening supply expectation due to regulatory measures on overproduction in coal mines [5] Investment Logic - The report suggests that the current thermal coal price has surpassed the second target price of around 700 CNY, with expectations to reach the third target price of 750 CNY, which is the breakeven point for coal and power generation companies [5][13] - Coking coal prices are expected to be influenced more by supply and demand fundamentals, with target prices set based on the ratio of coking coal to thermal coal prices [5][13] Investment Recommendations - The report identifies four main investment lines in the coal sector: 1. Cycle logic: Companies like Jinko Coal and Yancoal 2. Dividend logic: Companies like China Shenhua and China Coal Energy 3. Diversified aluminum elasticity: Companies like Shenhua Holdings and Electric Power Investment 4. Growth logic: Companies like Xinji Energy and Guanghui Energy [6][14]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company continues to show strong growth in H1 2025, driven by robust domestic demand recovery, with a significant increase in profitability [4][5] - The company achieved a revenue of 387 million yuan in H1 2025, representing a year-on-year growth of 29.38%, and a net profit attributable to shareholders of 84 million yuan, up 47.81% year-on-year [4][5] - The report maintains profit forecasts for 2025-2027, expecting net profits of 169 million yuan, 222 million yuan, and 272 million yuan respectively, with corresponding EPS of 1.01 yuan, 1.32 yuan, and 1.62 yuan [4][5] Financial Performance - In H1 2025, the company's core business, recombinant proteins, generated revenue of 319 million yuan, a year-on-year increase of 25.71% [5] - The company’s operating income for Q2 2025 was 201 million yuan, with a year-on-year growth of 30.95% and a quarter-on-quarter growth of 7.71% [4] - The net profit margin improved to 21.53% in H1 2025, up from 18.61% in 2024, due to effective cost control [6] Emerging Business Contributions - The company’s emerging business areas, particularly in cell and gene therapy (CGT) and antibody-drug conjugates (ADC), are becoming significant growth drivers, with CGT-related product revenue exceeding 20% of total revenue [5] - The domestic business revenue reached 123 million yuan in H1 2025, a year-on-year increase of 36.65%, indicating strong recovery in domestic demand [5] Valuation Metrics - The current stock price is 57.83 yuan, with a market capitalization of 9.707 billion yuan [1] - The price-to-earnings (P/E) ratios for 2025, 2026, and 2027 are projected to be 57.3, 43.7, and 35.7 respectively [4][8]

Report Summary 1. Report Industry Investment Rating No information provided in the content. 2. Core View of the Report - The current upward trend in the market may continue considering the favorable industry trends, abundant liquidity in the macro - environment, and the dovish expectations of the Federal Reserve [5][6]. - For AI and humanoid robots, the industry trends are clearly certain, and the trends are further strengthened with the explosion of computing power demand and continuous technological iteration and mass - production preparations of robots. Chinese enterprises' competitiveness has significantly increased, and the domestic chain is expected to gain a larger market share and value [5]. - In the current new upward cycle of convertible bonds, as the convertible bond market gradually rises and is in a combination of "high convertible bond price and moderate conversion premium rate", it is recommended to participate in equity - like convertible bonds of 120 yuan and above, focusing on the returns from the rise of the underlying stocks of convertible bonds [6]. 3. Summary by Relevant Catalogs Market Review - **Large - scale Asset Performance**: From August 18 - 22, 2025, the Shanghai Composite Index and the Wind All - A Index rose 3.49% and 3.87% respectively, with the average daily trading volume of the whole market reaching 2.59 trillion yuan. In the industry, communication, electronics, comprehensive, and computer sectors performed well. The S&P 500 rose 0.27%, and the Nasdaq fell 0.58%, fluctuating under the weak US employment and the dovish Federal Reserve [2]. - **Convertible Bond Market Performance**: The CSI Convertible Bond Index rose 2.83%. As of August 22, 2025, the median values of convertible bond price, conversion premium rate, and pure bond premium rate were 135 yuan, 27%, and 28% respectively. Some convertible bonds were subject to early redemption or non - early redemption, and some were subject to downward revision or non - downward revision of terms [2][3]. Market Dynamics - On August 22, 2025, Federal Reserve Chairman Powell hinted at the Jackson Hole meeting that the Fed might cut interest rates in the next few months despite the current inflationary risks, which was beneficial to equity risk assets [4]. - On August 19, 2025, Unitree Technology released a preview poster of a new humanoid robot, indicating a good trend in the humanoid robot industry [4]. - On August 21, 2025, DeepSeek's official Weibo message about a new domestic chip design drove up the domestic computing power chain [4]. - On August 22, 2025, it was reported that NVIDIA might have instructed its suppliers to stop producing products related to the H20 chip, and domestic computing power was expected to gradually replace it [4]. - Next - week events to watch include NVIDIA's Q2 earnings report, Huawei's new product launches, the HarmonyOS ecological conference, and the August PMI index [4]. Convertible Bond View - The convertible bond market continued its upward trend, mainly driven by the possible halt of NVIDIA's H20 production and the news about the next - generation domestic chip design, which might mean that domestic computing power chips could gradually replace NVIDIA's products and boost the expectations of the entire domestic chain. The humanoid robot industry also showed good development trends [5]. - Recommended Beneficiary Targets: Stable targets include Shanghai Bank, Changshu Bank, Hua'an, and Muyuan convertible bonds; flexible targets include Outech, Downturn, Jizhi, Yinlun, Yongsi, Dinglong, Limin, and Zhongchong Convertible Bond 2 [6].

Investment Rating - The investment rating for the pharmaceutical and biotechnology industry is "Positive" (maintained) [1] Core Insights - The PD-(L)1/VEGF dual antibody track is seeing accelerated overseas clinical development, with significant advancements in multiple clinical trials [5][20] - The report emphasizes the importance of monitoring upcoming clinical data releases and business development (BD) opportunities in the second tier of products [6][26] - The pharmaceutical and biotechnology sector experienced a 1.05% increase in the fourth week of August, underperforming the CSI 300 index by 3.13 percentage points [10][12] Summary by Sections 1. PD-(L)1/VEGF Dual Antibody Track - The first tier of PD-(L)1/VEGF dual antibodies has initiated overseas clinical trials, with Ivosidenib (康方生物/Summit) leading with over ten registered Phase III trials and nearly twenty ongoing overseas trials [5][20] - SSGJ-707 (三生制药/辉瑞) has commenced a head-to-head Phase III clinical trial in China for PD-L1 positive NSCLC and is expected to accelerate overseas clinical development [24] - PM8002 (普米斯/BioNTech/BMS) is exploring combination therapies with dual antibodies and ADCs, showing promising early data in various tumor types [23] 2. Upcoming Clinical Data and BD Opportunities - The report highlights the significance of upcoming clinical data releases for products like JS207 (君实生物), RC148 (荣昌生物), and others, which are expected to mature in the second half of 2025 [6][26] - The inclusion of RC148 in the breakthrough therapy designation (BTD) list marks it as the fourth PD-1/VEGF dual antibody in China, indicating a growing pipeline in this segment [14][16] 3. Recommended and Benefiting Companies - Recommended companies in the pharmaceutical and biotechnology sector include 恒瑞医药, 华东医药, 三生制药, and others, with a focus on various sub-sectors such as CXO, research services, traditional Chinese medicine, and medical devices [7][10]

Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Insights - The report indicates that the pig price is expected to gradually rise due to government storage initiatives, with the average pig price as of August 22, 2025, being 13.73 yuan/kg, showing a week-on-week increase of 0.04 yuan/kg but a year-on-year decrease of 6.51% [3][13] - The pet food export market is experiencing high growth, with July 2025 exports amounting to 130 million USD, a month-on-month increase of 13.35% [4][25] - The report highlights a positive outlook for the pig farming sector, driven by both fundamental and policy factors, with recommendations for specific companies in the sector [5][26] Weekly Observations - The report notes that the storage of frozen pork by the government is set to begin on August 25, 2025, with a total of 10,000 tons to be stored [38] - The average pig-to-grain price ratio has fallen below 6:1, prompting government intervention to stabilize the market [13][41] - The agricultural index outperformed the market by 0.23 percentage points during the week of August 18-22, 2025, with a 3.72% increase [30][33] Price Tracking - As of August 22, 2025, the average price of live pigs was 13.73 yuan/kg, with a slight decrease of 0.03 yuan/kg from the previous week [43][44] - The average price of piglets was 27.78 yuan/kg, down 1.09 yuan/kg week-on-week [43][44] - The report also tracks the prices of other agricultural products, noting fluctuations in beef, chicken, and feed prices [42][54] Recommendations - The report recommends several companies for investment, including Muyuan Foods, Wens Foodstuff Group, and others in the pig farming sector, as well as companies in the feed sector like Haida Group and New Hope [5][26][28] - In the pet food sector, companies such as Guibao Pet and Petty are highlighted as strong investment opportunities due to the rising domestic market [5][29]

Group 1 - The report indicates that both the North Exchange 50 and the Specialized and Innovative Index have reached historical highs, with the North Exchange 50 expected to establish a new range between 1450 and 1650 points [2][10][24] - The North Exchange 50 index closed at 1,600.27 points with a TTM PE of 72.98X, while the Specialized and Innovative Index closed at 2,785.76 points with a TTM PE of 86.13X, reflecting significant weekly increases of 8.40% and 8.86% respectively [3][28][32] - The North Exchange has a high concentration of "specialized and innovative" companies, with 54.48% classified as national-level specialized and innovative small giants, which is only slightly lower than the Sci-Tech Innovation Board [2][12][24] Group 2 - The North Exchange exhibits a stronger high-beta characteristic compared to other boards, with a 30% price fluctuation limit, leading to significant price elasticity due to marginal changes in capital flow [17][24] - The report highlights that the North Exchange is expected to benefit from the arrival of index-based investments, which will provide investors with a richer array of investment tools, potentially leading to liquidity improvements and ecological restructuring [2][20][24] - The report emphasizes the scarcity and innovative productivity represented by specialized small giants in the North Exchange, suggesting that companies with unexpected strong performance in their semi-annual reports should be closely monitored [2][35][42]